$BKSY Balance Sheet | Understand Stock

$BKSY

$17.84 +$0.26 (1.48%) Close

$BKSY Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Restricted cash
Short-term investments
Accounts Receivable
Related Party
Total accounts Receivable
Amounts receivable from equity method investees
Contract assets
Inventories
Prepaid Expense and Other Assets, Current
Total current assets
Property and equipment - net
Operating lease right of use assets - net
Goodwill
Investment in equity method investees
Satellite procurement work in process
Intangible assets - net
Satellite work in process
Other assets
Total assets
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable and accrued liabilities
Amounts payable to equity method investees
Accounts payable
Related Party
Total accounts payable

Debt - current portion
Contract liabilities - current
Debt, Current
Other current liabilities
Related Party
Total other current liabilities
Total current liabilities

Liability for estimated contract losses
Long-term contract liabilities
Operating lease liabilities
Derivative liabilities
Deferred revenue - long-term
Long-term debt - net of current portion
Other liabilities
Total liabilities
Stockholders’ equity:
Preferred stock, $0.0001 par value; 100,000 shares authorized; none issued or outstanding.
Class A common stock, $0.0001 par value-authorized, 300,000 shares; issued, 40,925 and 36,227 shares; outstanding, 40,628 shares and 35,930 shares as of June 30, 2026 and December 31, 2025, respectively.
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity

Total liabilities and stockholders’ equity

Common stock, shares issued (in shares)
Common stock shares outstanding (in shares)

Comments